Reports and Recordings | Medicines Discovery Catapult

Who we help
- - - Our Collaborators
    - Our collaborators come from a broad range of sectors and backgrounds. We support their shared desire to advance medicines discovery through innovative science.
How we help
- - - Success Stories
    - Our work is reshaping the medicines discovery industry. We’ve got numerous innovative success stories to share with you.
  - - Partnership Opportunities
    - We can help find relevant funding opportunities, and access specialist skills and resources from our partners. We can join grant applications as a collaborator or subcontractor.
Expert team
- - - Our team has decades of experience across big pharma, academia, leading technology providers, SMEs, charities and start-ups. They are at the cutting-edge of their respective fields. They are innovators and thought leaders, and the honest independent advice they provide is what makes them valuable to our collaborators.
Resources
- - - Find out all the latest news from MDC and our collaborators, read our latest blog posts and reports, and catch up with us at webinars and events.
    - News
    - Blog
    - Reports and Recordings
    - Events & Webinars
    - Publications
Lighthouse Lab
Get in touch

State of the Discovery Nation 2021

Complex medicines will become as important as traditional small molecule drugs in the coming years, with market values of hundreds of billions of pounds. Pharmaceutical and biotech companies working in complex medicines in the UK include those specialising in antibody-drug conjugates, firms developing oligonucleotide therapeutics, entities focusing on proprietary delivery technologies for a range of […]

Webinar – Complex Medicines: Ready for the Clinic/Scaling up for Success

The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs. MDC Connects 2021: A Guide to Complex Medicines is a […]

Webinar – Complex Medicines: Understanding Safety & Efficacy

The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs. MDC Connects 2021: A Guide to Complex Medicines is a […]

Webinar – Complex Medicines: A Glance at Novel Drug Delivery Systems

The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs. MDC Connects 2021: A Guide to Complex Medicines is a […]

Webinar – Complex Medicines: Understanding the Interplay with Biological Systems

The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs. MDC Connects 2021: A Guide to Complex Medicines is a […]

Webinar – Complex Medicines: Selection and Characterisation of the Lead

The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs. MDC Connects 2021: A Guide to Complex Medicines is a […]

Webinar – Complex Medicines: Why? What? When? Opportunities and Challenges

The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs. MDC Connects 2021: A Guide to Complex Medicines is a […]

Proposed Definition of ‘Complex Medicine’

In a quest to address novel and previously intractable targets, drug discovery is undergoing a rapid transition from traditional small molecule and antibody approaches to a more diverse range of therapeutic modalities, including RNA therapeutics and antibody-drug conjugates. These exciting new approaches raise challenges as well as opportunities, with a critical need for development of […]

A roadmap for the discovery of therapeutics in healthy ageing

This report was produced in collaboration with colleagues at the Medicines Discovery Catapult, a UK SPINE partner. It is a guide to established best practice in drug discovery with a focus on interrogating the aetiology of age-associated multimorbidity. It complements the drug discovery roadmap, case studies drawn from recent clinical trials illustrate regulatory strategies for […]